Skip to main content

Revvity signals beyond the news: 20 signals from 3 sources

The latest Revvity signal on this page is from Oct 27, 2026 (Patents): "REVVITY HEALTH SCIENCES, INC.'s patent output is steady: 10 grants in the past year, 1 in the past 30 days." The busiest sources: Glassdoor (14), Reddit (3) and Patents (3).

PublicBiotechnology Research1,001 to 5,000 employeesrevvity.comLinkedIn

Get Revvity's live signals in Claude or ChatGPT, or by API

AskWhat changed at Revvity this week? Use Autobound signals for revvity.com.
Signals
20
Sources
3
Last 90 days
16
Latest
Oct 27, 2026

Source: Autobound Signal API · 23 signals tracked for Revvity · updated

Other signals · latest 10

Latest Revvity signals by source

20 signals for Revvity across 3 sources.

  1. Patents · Patent pace

    REVVITY HEALTH SCIENCES, INC.'s patent output is steady: 10 grants in the past year, 1 in the past 30 days.

    Over the past year REVVITY HEALTH SCIENCES, INC. received 10 US patent grants; the recent pace (1 in 90 days) is steady versus its trailing baseline.

    Grants, 12 months
    10
    Grants, 90 days
    1
    Grants, 30 days
    1
    USPTO assignee
    Revvity Health Sciences, Inc.

    Google Patents

  2. Reddit · Customer feedback

    Revvity (PerkinElmer) customer expresses frustration over spending a week in unhelpful email correspondence trying to obtain 17-year-old legacy software required to operate an Enspire 2300 plate...

    Post: "Dear lab supply companies - please give me the free software to the $20k instrument I already own"

    Subreddit
    r/labrats
    Upvotes
    839
    Comments
    53
    Sentiment
    Negative

    r/labrats

  3. Glassdoor · Acquisition integration issues

    Company integration challenges create uncertainty and impact small businesses

    A manager notes that constant changes from integrating newly acquired companies create uncertainty and effectively sideline smaller businesses within the organization, impacting their development.

    Overall rating
    3.7 of 5
    CEO approval
    81%
    Reviews read
    7
    Review window
    Sep 11, 2026 to Oct 9, 2026

    Glassdoor

  4. Glassdoor · Compensation dissatisfaction

    Revvity employees report pay below industry standards and raise concerns

    Two reviewers mention low pay compared to industry standards in California and frustration with salary progression, with one noting that pay bumps are needed to attract and retain staff.

    Overall rating
    3.7 of 5
    CEO approval
    81%
    Reviews read
    7
    Review window
    Sep 11, 2026 to Oct 9, 2026

    Glassdoor

  5. Glassdoor · Growth opportunities

    Employees cite unclear promotion paths and limited career development

    Three employees report a lack of clarity regarding promotion criteria and limited opportunities for career progression and skill development within the company.

    Overall rating
    3.7 of 5
    CEO approval
    81%
    Reviews read
    7
    Review window
    Sep 11, 2026 to Oct 9, 2026

    Glassdoor

  6. Glassdoor · Talent retention concerns

    High turnover and minimal staffing lead to overworked employees

    One technologist states there is high turnover and employees are overworked due to minimal staffing, hindering the ability to secure new hires and retain current staff.

    Overall rating
    3.7 of 5
    CEO approval
    81%
    Reviews read
    7
    Review window
    Sep 11, 2026 to Oct 9, 2026

    Glassdoor

  7. Patents · Patent counsel

    REVVITY HEALTH SCIENCES, INC. uses Seed Intellectual Property Law Group LLP as outside IP counsel.

    Seed Intellectual Property Law Group LLP is the attorney of record on REVVITY HEALTH SCIENCES, INC.'s recent US patent work, including a grant in 2026-09.

    Law firm
    Seed Intellectual Property Law Group LLP
    Law firm domain
    seedip.com
    Matter date
    Sep 29, 2026

    Google Patents

  8. Patents · Patent grant

    Revvity Health Sciences was granted a patent for multiplexed PCR automation.

    In September 2026 Revvity Health Sciences patented a compact system for running multiplexed PCR tests in research and clinical laboratories.

    Patent title
    Multiplexed polymerase chain reaction in micropipette format
    Grant date
    Sep 29, 2026
    Inventors
    Andrew Brodsky

    Google Patents

  9. Reddit · Buying intent

    A researcher is evaluating Revvity alongside its Horizon Discovery unit to purchase sgRNA reagents for an arrayed CRISPRa screen of 200-300 genes.

    Post: "CRISPRa arrayed screen"

    Subreddit
    r/labrats
    Upvotes
    1
    Comments
    2
    Sentiment
    Neutral

    r/labrats

  10. Reddit · Product change

    Revvity has discontinued the free version of ChemSketch software following its recent acquisition of the original developer, ACD/Labs.

    Post: "No more free ChemSketch"

    Subreddit
    r/Chempros
    Upvotes
    90
    Comments
    40
    Sentiment
    Negative

    r/Chempros

Showing 10 of 20 signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Revvity with the Signal API

One POST /v1/companies/enrich call with revvity.com returns Revvity signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "revvity.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Revvity other signals

What signals does Autobound track for Revvity besides news and filings?
This page lists 20 signals for Revvity from 3 sources: Glassdoor (14), Reddit (3) and Patents (3). Every row is dated, and most link to the post, review or record.
What are people saying about Revvity online?
The newest posts on this page: Oct 21, 2026, Reddit (r/labrats): Revvity (PerkinElmer) customer expresses frustration over spending a week in unhelpful email correspondence trying to obtain 17-year-old legacy software required to operate an Enspire 2300 plate... Aug 30, 2026, Reddit (r/labrats): A researcher is evaluating Revvity alongside its Horizon Discovery unit to purchase sgRNA reagents for an arrayed CRISPRa screen of 200-300 genes. Aug 18, 2026, Reddit (r/Chempros): Revvity has discontinued the free version of ChemSketch software following its recent acquisition of the original developer, ACD/Labs.
What do employees say about working at Revvity?
The newest Glassdoor theme on this page, dated Oct 9, 2026: Company integration challenges create uncertainty and impact small businesses. The overall rating in that row is 3.7 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Revvity been granted patents recently?
Yes. The newest grant on this page: Sep 29, 2026, Patents (Google Patents): Revvity Health Sciences was granted a patent for multiplexed PCR automation.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →